Kobo Biotech Ltd Stock Analysis

BSE: 531541 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 27-Jan-2023 18:01
3.49 -0.17 (-4.64%)

DeciZen - Make an Informed Decision on Kobo Biotech

M-Cap below 100cr DeciZen not available

Kobo Biotech Price Chart

P/E Ratio ( SA) :
Market Cap :
8.7 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Kobo Biotech Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Kobo Biotech Ltd is a average quality company.

2. Is Kobo Biotech Ltd undervalued or overvalued?

The key valuation ratios of Kobo Biotech Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Kobo Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Kobo Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Kobo Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kobo Biotech Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 10.3%-11.1%-12.7%-4.5%-5.2%-7.5%-7.9%-7.4%-7.1%-0.4%-
Value Creation Index -0.3-1.8-1.9-1.3NANANANANANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 17056.929.132.50000000
YoY Gr. Rt. %--66.6%-48.9%12%-100%NANANANANA-
Adj EPS 3.7-15.3-14.4-7.2-8-10.1-10-9.4-7.9-0.2-6
BVPS (₹) 34.319.86.10.2-7.8-17.8-28.1-36.9-45-51.4-52.5
Adj Net Profit 8.3-34.3-32.4-17.1-19.2-24-23.8-22.4-18.8-0.4-14
Cash Flow from Ops. 38.41119.35.632.331.52114.52.593.8-
Debt/CF from Ops. 3.412.47.427.


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%NANANA
Adj EPS -171.5%NANANA
BVPS -204.6000
Share Price -18.9% -25.4% 2% -54.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 11.3-56.4-111.1-170.2315.378.543.528.919.30.411.6
Op. Profit Mgn % 21-12.2-34.211.90000000
Net Profit Mgn % 4.9-60.3-111.4-52.60000000
Debt to Equity
Working Cap Days 2819881,8751,6750000000
Cash Conv. Cycle 1666411,2357110000000

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 11.60%

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Kobo Biotech Ltd.

Standalone Consolidated
TTM EPS (₹) -6 -14.6
TTM Sales (₹ Cr.) 0 103
BVPS (₹.) -52.5 0
Reserves (₹ Cr.) -149 31
P/BV -0.07 0.00
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 3.48 / 8.64
All Time Low / High (₹) 1.19 / 82.55
Market Cap (₹ Cr.) 8.7
Equity (₹ Cr.) 23.8
Face Value (₹) 10
Industry PE 36

Management X-Ray of Kobo Biotech :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Kobo Biotech

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Kobo Biotech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Kobo Biotech on 27-Jan-2023 18:01 is : 3.49.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Jan-2023 18:01 the market cap of Kobo Biotech stood at ₹ 8.72.
The latest PE ratio of Kobo Biotech as of 27-Jan-2023 18:01 is 0.00.
The latest PB ratio of Kobo Biotech as of 27-Jan-2023 18:01 is -0.07
The 52-week high of Kobo Biotech is ₹ 8.64 and the 52-week low is ₹ 3.48.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Kobo Biotech is ₹ 0.00 ( Cr.) .

About Kobo Biotech Ltd

AVON Organics Limited (AOL) was started by P R Agarwal, Rajesh Agarwal along with late G S Sidhu .It is located at Madhupala Towers Greenlands, Hyderabad 500 016, India. The company's transition from a machinery manufacturer to a full-fledged chemical manufacturer saw the company foraying into the highly technology-intensive area of Diketene and its derivatives.

In the year 1996 the company established and successfully commissioned its first grass root Diketene plant .It has doubled its production capacity by commissioning an additional 1000 TPA unit as part of its second phase in 1998.  It is an ISO 9000 certification by the Lloyds Register Quality Assurance (LRQA).

Business profile:

A keen insight and a well-planned development process saw AOL discover the opportunity in the production of Diketene - the basic unit for hundreds of derivatives in pesticides, chemicals, pharmaceuticals and dyestuffs. A highly classified technology, it has been sourced from Shanghai Peng Pu Chemical Works, China, and Xytel Technology Partnership, USA, and now rests in the hands of a few chosen manufacturers across the globe.

The company, with its immense infrastructure framework has introduced modifications to the Chinese technology and has a current production of 3000 tonnes per annum against an installed capacity of 2000 tonnes per annum. A sprawling facility of 21 acres, the plant is situated 60 kilometers from Hyderabad. The locale is ideal due to its easy connectivity made possible by the well-traversed National Highway # 9 that links Hyderabad with Mumbai.

Products :

  • Diketene:
  • Pharmaceutical intermediates
  • Agrochemical intermediates
  • Pigment intermediates 

Pharmaceutical (Including Ephedrines) :

  • Active Pharmaceutical ingredients
  • Pharma intermediates
  • Formulation intermediates 
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now